These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11099317

  • 1. Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer.
    Morse MA, Nair S, Fernandez-Casal M, Deng Y, St Peter M, Williams R, Hobeika A, Mosca P, Clay T, Cumming RI, Fisher E, Clavien P, Proia AD, Niedzwiecki D, Caron D, Lyerly HK.
    J Clin Oncol; 2000 Dec 01; 18(23):3883-93. PubMed ID: 11099317
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice.
    Masten BJ, Olson GK, Kusewitt DF, Lipscomb MF.
    J Immunol; 2004 Apr 01; 172(7):4077-83. PubMed ID: 15034019
    [Abstract] [Full Text] [Related]

  • 4. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
    Chen W, Chan AS, Dawson AJ, Liang X, Blazar BR, Miller JS.
    Biol Blood Marrow Transplant; 2005 Jan 01; 11(1):23-34. PubMed ID: 15625541
    [Abstract] [Full Text] [Related]

  • 5. Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells.
    Teleshova N, Jones J, Kenney J, Purcell J, Bohm R, Gettie A, Pope M.
    J Leukoc Biol; 2004 Jun 01; 75(6):1102-10. PubMed ID: 15075365
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice.
    Pawlowska AB, Hashino S, McKenna H, Weigel BJ, Taylor PA, Blazar BR.
    Blood; 2001 Mar 01; 97(5):1474-82. PubMed ID: 11222396
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Flt3 Ligand Is Essential for Survival and Protective Immune Responses during Toxoplasmosis.
    Dupont CD, Harms Pritchard G, Hidano S, Christian DA, Wagage S, Muallem G, Tait Wojno ED, Hunter CA.
    J Immunol; 2015 Nov 01; 195(9):4369-77. PubMed ID: 26385522
    [Abstract] [Full Text] [Related]

  • 19. Flt3 ligand bioactivity and pharmacology in neoplasia.
    Reber AJ, Ashour AE, Robinson SN, Talmadge JE, Solheim JC.
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun 01; 4(2):149-56. PubMed ID: 15180455
    [Abstract] [Full Text] [Related]

  • 20. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D, Perrin M, Hoffmann S, Chang AE, Ratanatharathorn V, Uberti J, McDonagh KT, Mulé JJ.
    Clin Cancer Res; 1998 Nov 01; 4(11):2709-16. PubMed ID: 9829733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.